Leonie Jaspers

Title: Leonie Jaspers: Innovator in Huntington's Disease Research

Introduction

Leonie Jaspers is a notable inventor based in Maastricht, Netherlands. She has made significant contributions to the field of genetic research, particularly in relation to Huntington's disease. Her innovative work focuses on methods to suppress the expression of mutated huntingtin protein, which is crucial for developing potential therapies for this debilitating condition.

Latest Patents

Leonie Jaspers holds a patent for "Methods and sequences to preferentially suppress expression of mutated huntingtin." This patent discloses methods and sequences designed to preferentially suppress the expression of the mutated huntingtin ('htt') protein over the normal htt protein. The patent also includes methods for screening individuals for the heterozygous presence of single nucleotide polymorphisms within their Huntington's genes. Furthermore, it describes the administration of nucleic acid molecules that target the mutated protein while sparing the normal variant, offering a promising avenue for therapeutic intervention.

Career Highlights

Throughout her career, Leonie has worked with prominent companies in the medical field, including Medtronic, Inc. and Medtronics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts and contribute to groundbreaking research in genetic therapies.

Collaborations

Leonie has collaborated with notable professionals in her field, including Paul H. J. Van Bilsen. These partnerships have enhanced her research and expanded the impact of her innovations.

Conclusion

Leonie Jaspers is a pioneering inventor whose work in suppressing mutated huntingtin expression holds great promise for Huntington's disease treatment. Her contributions to genetic research and collaboration with leading companies and experts underscore her commitment to advancing medical science.